Written and medically reviewed by: Assoc. Prof. Cengiz Dibekoğlu, MD, General SurgeryLast updated:
Liver Disease — Liver Tumors
Benign vs malignant liver tumors — hemangioma, FNH, adenoma, HCC, and metastases need distinct evaluation and treatment pathways.
Most incidental liver lesions are benign. Hemangiomas and FNH are usually observed; adenomas may need resection based on size, sex/hormone factors, and bleeding risk. Hepatocellular carcinoma arises chiefly on cirrhotic backgrounds. Colorectal and other metastases may be resectable or ablatable in selected oligometastatic patterns after oncology staging. Lesion label and underlying liver function must be read together before any procedure talk.
Educational schematic. Some structures may be simplified or emphasized for clarity; not an exact anatomical depiction.
© Cengiz Dibekoğlu — illustrative; not for unauthorized use
Figure summary
This educational figure shows: Tumors.
Who may be a candidate?
- International patients preparing a structured second-opinion visit
- Patients comparing observation, medical care, and procedural options
Possible advantages
- Supports informed consent with alternatives and recovery themes
- Highlights red flags that should trigger urgent contact
Limits & realistic expectations
- Cannot replace examination, imaging, or pathology
- Local hospital protocols and specialist review may refine timing
- Outcomes vary with anatomy, stage, and comorbidity
Step-by-step overview
- 1
Clarify the clinical question
What diagnosis is being confirmed and what decision follows?
- 2
Choose first-line tests
Start with the test that answers the leading question safely.
- 3
Stage if needed
Add imaging or endoscopy when results would change management.
- 4
Name limitations
No test replaces exam; false reassurance is a risk.
- 5
Link to next step
Diagnosis should point to observation, medical care, or procedure.
Key points
- Key note inside
Important
This page is for education. It is not medical advice and does not replace a visit with your physician.
Frequently asked questions
Are all liver lesions cancer?
No. Hemangiomas and other benign lesions are common; multiphase imaging distinguishes many of them.
What is different about HCC planning?
Liver function and portal hypertension matter as much as tumor size.
Can metastases still be resected?
Selected metastases are treated with resection or ablation inside a multidisciplinary plan.
When is biopsy needed?
When imaging is inconclusive or histology would change therapy.
More chapters in this hub
Liver Cysts
Simple vs complex cysts — when observation is enough
Hydatid Cyst
Echinococcosis — albendazole, PAIR, and surgery
Liver Disease Diagnosis
How clinicians confirm the problem and stage the next steps
Colorectal liver metastases
When colon or rectal cancer has spread to the liver
Liver Disease Treatment
How treatment options are matched to risk, stage, and goals
Fatty Liver Disease
MASLD / MASH (formerly NAFLD / NASH) and metabolic risk
Viral Hepatitis
Hepatitis B and C — chronic care
Liver Abscess
Fever, drainage, and antibiotics
FNH and Adenoma
Benign solid liver lesions
Liver Hemangioma
Common benign vascular tumor
Cirrhosis
Chronic injury and complications
Variceal Bleeding
Portal hypertension emergency
Appointment / info
This page is for education. It is not medical advice and does not replace a visit with your physician.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.